English
Español
Lung Cancer Clinic
Each year more than 200,000 people are diagnosed with lung cancer. However, despite the serious nature of lung cancer, the prognosis for beating it is much better than it was even five years ago, thanks to early detection efforts and new treatment strategies.
Esophageal Cancer Clinic
Esophageal cancer accounts for more than 16,000 new cases each year. Thanks to improved treatments and early intervention, the survival rates for esophageal cancer have improved greatly since the 1960s when only a small percentage of people with the disease survived more than five years.
Mesothelioma Clinic
Most mesotheliomas begin in the chest cavity. Though fairly rare, there are still about 2,000 to 3,000 new cases each year, primarily in men over 65. Early detection and intervention by doctors at the Florida Hospital Cancer Institute's thoracic program is essential in treating the disease.
Lung Nodule Clinic
The presence of lung nodules does not automatically signal that you have cancer. Benign nodules can actually be quite common. To ensure that the nodules aren't cancerous, doctors at FHCI will monitor changes in size, shape or appearance through regular tests.
Uncommon Malignancies Clinic
Rare forms of cancer include carcinoid tumors, mediastinal tumors and thymoma. Each of these presents unique challenges that doctors at the Florida Hospital Cancer Institute address with a broad range of traditional and leading edge treatment strategies.
Who We Are
Jose Nieto, DO
Learn more about the role of the gastroenterologist in the treatment of thoracic cancer.
Joseph Boyer, MD
Learn more about the role of the thoracic surgeon in the treatment of thoracic cancer.
Sigfredo Aldarondo, MD
Learn more about the role of the pulmonologist in the treatment of thoracic cancer.
Florida Hospital Cancer Institute Welcomes Dr. Tarek Mekhail
Printer-friendly version
Send to friendFlorida Hospital Cancer Institute is pleased to welcome Tarek Mekhail, M.D., MSc, FRCSI, FRCSEd as the newest member of the Cancer Institute of Florida. Mekhail will serve as the Medical Director of the Thoracic Cancer Program for Florida Hospital Cancer Institute.
Prior to joining Florida Hospital Cancer Institute, Mekhail served as Director of the Lung Cancer Medical Oncology Program at Cleveland Clinic's Taussig Cancer Center since 2002. Mekhail is board certified in hematology, medical oncology and internal medicine. He is a national and international clinical investigator and his specialties include lung cancer, head and neck cancer, kidney cancer, aerodigestive malignancies and the development of novel agents for the treatment of diseases.
Dr. Mekhail received his medical degree from Cairo University, Egypt, in 1984. He completed ear, nose and throat (ENT) and head and neck surgery training at Cairo University and subsequently in the United Kingdom. He is a fellow of the Royal College of Surgeons in Ireland and the Royal College of Surgeons of Edinburgh in Scotland. Mekhail completed his internal medicine residency and fellowship in hematology and medical oncology at the Cleveland Clinic.
Mekhail has authored and co-authored more than 100 peer-reviewed articles, abstracts for medical journals and book chapters, in his field. He is a member of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer, among others. He was selected by Best Doctors Inc. as "Best Doctor in America" and by Cleveland Magazine as "Best Doctor in Ohio" in 2007 and 2008.
